id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0284-0007,FDA,FDA-2012-N-0284,FDA CDER Memorandum December 5 2012 re for use of Sodium Nitroprusside to Reduce Blood Pressure  in Pediatric Patients,Other,Memorandum,2012-12-05T05:00:00Z,2012,12,2012-12-05T05:00:00Z,,2013-12-24T14:07:35Z,,0,0,090000648117fc9d
FDA-2012-N-0284-0006,FDA,FDA-2012-N-0284,Memorandum for the Record re Sodium Nitroprusside I71 979 Public Comment Docket,Other,Memorandum,2012-11-08T05:00:00Z,2012,11,2012-11-08T05:00:00Z,,2013-12-24T14:02:06Z,,0,0,0900006481163ac1
FDA-2012-N-0284-0004,FDA,FDA-2012-N-0284,National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) Part 3 of 3 - Report,Other,Report,2012-11-02T04:00:00Z,2012,11,2012-11-02T04:00:00Z,,2012-11-02T14:58:03Z,,0,0,0900006481136c92
FDA-2012-N-0284-0003,FDA,FDA-2012-N-0284,National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) Part 2 of 3 - Report,Other,Report,2012-11-02T04:00:00Z,2012,11,2012-11-02T04:00:00Z,,2012-11-02T14:56:32Z,,0,0,0900006481136c91
FDA-2012-N-0284-0002,FDA,FDA-2012-N-0284,National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) Part 1 of 3 - Report,Other,Report,2012-10-04T04:00:00Z,2012,10,,,2012-11-02T17:03:59Z,,0,0,090000648113398b
FDA-2012-N-0284-0001,FDA,FDA-2012-N-0284,"Pediatric Studies of Sodium Nitroprusside, etc.; Availability",Notice,General Notice,2012-10-03T04:00:00Z,2012,10,2012-10-03T04:00:00Z,2012-11-03T03:59:59Z,2012-10-16T02:01:35Z,2012-24213,0,0,090000648113287d